Zobrazeno 1 - 10
of 189
pro vyhledávání: '"George W. Santos"'
Publikováno v:
Cancer. 36:1950-1958
Cyclophosphamide (CY) in a total dose of 120 mg/kg was given over 2 days on one to three occasions to 12 patients with a variety of nonlymphoid solid tumors. Two of 10 patients with measurable disease had a partial response. One had embryonal rhabdom
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f83368fafea0f944c3d6685eec46cc64
https://doi.org/10.1002/cncr.2820360604
https://doi.org/10.1002/cncr.2820360604
Publikováno v:
The Oncologist. 6:114-117
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::00a45c2b9ef7c7a7e209b66946ecbae7
https://doi.org/10.1634/theoncologist.6-2-114
https://doi.org/10.1634/theoncologist.6-2-114
Publikováno v:
STEM CELLS. 19:95-98
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a88299e2f14930703f8776f42624e8ec
https://doi.org/10.1634/stemcells.19-2-95
https://doi.org/10.1634/stemcells.19-2-95
Siegmund J. Baum It has become a tradition to commence advocated by Leonard Cole) (3). important meetings of this society with At about the same time, Alpen and reminiscence and nostalgia. Bone marrow Baum (4), using a larger mammal, the dog, transpl
Autor:
George W. Santos
Publikováno v:
Annals of the New York Academy of Sciences. 770:1-7
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ef15f6a8c8e89a4ad01ec6de1b36effc
https://doi.org/10.1111/j.1749-6632.1995.tb31039.x
https://doi.org/10.1111/j.1749-6632.1995.tb31039.x
Autor:
George W. Santos
Publikováno v:
Current Opinion in Oncology. 6:115-121
Supraintensive cytoreductive therapy with hematopoietic stem cell rescue (HSCR) is able to provide curative therapy in a number of hematologic malignancies. Allogeneic HSCR is limited to less than 50% of patients because of the absence of related or
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d32bcfc434c938fcd4a9d860c6977992
https://doi.org/10.1097/00001622-199403000-00001
https://doi.org/10.1097/00001622-199403000-00001
Autor:
Andrew M. Yeager, Georgia B. Vogelsang, Evan R. Farmer, George W. Santos, Allan D. Hess, Richard J. Jones
Publikováno v:
Leukemia & Lymphoma. 11:215-220
Rodents given cyclosporine (CSP) for several weeks after autologous or syngeneic bone marrow transplantation develop a syndrome that mimics allogeneic graft-versus-host disease (GVHD). Autologous GVHD has also been reported after administration of CS
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::76beacd766d5de8a3f50a2b7f48cb0b6
https://doi.org/10.3109/10428199309086998
https://doi.org/10.3109/10428199309086998
Autor:
George W. Santos
Publikováno v:
Leukemia & Lymphoma. 11:201-204
Allogeneic bone marrow transplantation (BMT) for chronic myelogenous leukemia (CML) offers the only significant chance of cure for this disease. About 50% of patients transplanted in the 1980s appear to be cured and with subsequent advances, it is su
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e7b49e396b30e6df6499c2148f0b0046
https://doi.org/10.3109/10428199309047886
https://doi.org/10.3109/10428199309047886
Autor:
Carole B. Miller, Steven Piantadosi, Richard J. Jones, George W. Santos, William H. Burns, Mariana L. Zahurak, Jerry L. Spivak
Publikováno v:
Blood. 80:2677-2682
Delayed erythroid recovery is common after bone marrow transplantation (BMT), with some patients continuing to require red blood cell (RBC) transfusion support for as long as 1 year. While the etiology is multifactorial, inadequate stimulation of ery
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dfc36817e3310a9d3752acb82333f9c9
https://doi.org/10.1182/blood.v80.10.2677.2677
https://doi.org/10.1182/blood.v80.10.2677.2677
Autor:
John E. Wagner, George W. Santos, Andrew M. Yeager, Michael L. Graham, Richard J. Jones, Louise B. Grochow
Publikováno v:
Blood. 80:2425-2428
Busulfan (BU) is a widely used myeloablative and antineoplastic agent in clinical bone marrow transplantation (BMT). The lower incidence of BU-associated toxicities and lower therapeutic effectiveness in young children given BU doses based on body we
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d5808085b6f151cbf3ae4902d3b27173
https://doi.org/10.1182/blood.v80.9.2425.bloodjournal8092425
https://doi.org/10.1182/blood.v80.9.2425.bloodjournal8092425